search
Back to results

Reduction of Trauma-induced Intrusions and Amygdala Hyperreactivity Via Non-invasive Brain Stimulation (COOL)

Primary Purpose

Intrusive Thoughts, Post Traumatic Stress Disorder

Status
Unknown status
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
iTBS
Placebo iTBS
Sponsored by
University Hospital, Bonn
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Intrusive Thoughts focused on measuring Amygdala, fMRI, Intrusive Thoughts, Post Traumatic Stress Disorder, TMS

Eligibility Criteria

18 Years - 45 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Healthy subjects

Exclusion Criteria:

  • current psychiatric illness
  • current psychiatric medication or psychotherapy
  • past PTSD diagnosis
  • MRI contraindication (e.g. metal in body, claustrophobia)
  • pregnancy

Sites / Locations

  • Department of Psychiatry, University of BonnRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Active iTBS

Placebo iTBS

Arm Description

Active stimulation of the dlPFC directly after trauma exposure and on the following two days

Same procedure as in the active stimulation group but with a placebo stimulation imitating the sensation of a real iTBS protocol.

Outcomes

Primary Outcome Measures

Number and quality of intrusive thoughts
Sum and stress ratings of intrusive thoughts measured on three consecutive days after trauma exposure by an online questionnaire.
Changes in resting state functional connectivity
Functional connectivity data will be assessed by two 10-minutes resting state fMRI scans before and after three sessions of TMS treatment over the course of three days. The resting state fMRI analysis will focus on changes in functional connectivity between regions-of-interest (ROIs) associated with intrusive memories (prefrontal cortex, amygdala, precuneus, insula, hippocampus, cingulate cortex). Changes in functional connectivity between the first and second fMRI sessions will be computed on the first level and independent t-tests will be used to compare the verum and sham TMS groups.
Changes in neural response to an emotion recognition task
Changes between the first and second fMRI session in the blood-oxygen-level-dependent (BOLD) signal in response to happy, fearful and neutral faces as well as houses will be compared between the experimental groups. Analysis will focus on anatomically defined regions-of-interest (ROI) associated with emotion processing (i.e. amygdala, prefrontal cortex, insula, striatal areas). Changes in the neural response and functional connectivity between the first and second fMRI sessions will be computed on the first level and independent t-tests will be used to compare the verum and sham TMS groups. For analyses of fMRI data, standard procedures of the software SPM12 will be used.

Secondary Outcome Measures

Changes in executive functioning (One Touch Stockings of Cambridge) and attention (Rapid Visual Information Processing) during iTBS treatment
Cognitive tasks conducted with the CanTab software will be used to measure executive functioning (One Touch Stockings of Cambridge) and attention (Rapid Visual Information Processing) on four different time points during the treatment (pre/post first iTBS, pre/post last iTBS). Changes in executive functioning and attention will be tested as moderator variables of other TMS effects.
Trauma disclosure
Trauma disclosure will be measured by online questionnaires on days 2-4. Subjects will be asked to report the number and duration (in minutes) of conversations about the video. Furthermore, subjects have to report to who they talked with about the video. Trauma disclosure will be tested as a moderator variable of TMS effects.
Changes in electrodermal responses to the trauma video
Electrodermal responses will be recorded by a BioNomadix System (BIOPAC Systems Inc., Santa Barbara, USA) during a 5-minutes baseline before the start of the trauma video and during the trauma video with two electrodes attached to palm of the right hand.
Respiratory changes in response to the trauma video
Respiratory rate will be recorded by a BioNomadix System (BIOPAC Systems Inc., Santa Barbara, USA) during a 5-minutes baseline before the start of the trauma video and during the trauma video with belt attached to the subject's chest. Data will be analyzed for changes in breathing frequency and amplitude in response to the trauma video.
Heart rate changes in response to the trauma video
Heart rate will be recorded by a BioNomadix System (BIOPAC Systems Inc., Santa Barbara, USA) during a 5-minutes baseline before the start of the trauma video and during the trauma video.
Changes in positive and and negative affect in response to the trauma video
Changes in positive and negative affect will be measured by the PANAS (Positive and Negative Affect Schedule) questionnaire 10 minutes before and 10 minutes after trauma exposure. The PANAS questionnaire consists of two subscale: 1. positive affect (minimum rating = 5, maximum rating = 50), 2. negative affect (minimum rating = 5, maximum rating = 50).
Changes in anxiety in response to the trauma video
Changes in anxiety will be measured by the STAI-Trait (State-Trait Anxiety Inventory) questionnaire immediately 10 minutes before and 10 minutes after trauma exposure.(minimum rating = 20, maximum rating = 80, higher values indicate more state anxiety).
Dissociative symptoms after trauma exposure
Dissociative symptoms after the trauma video will be measured by questionnaires (Dissociation-Tension-Scale acute) and tested as a moderator variable of TMS effects. Subjects score between 0 and 9, with higher values indicating more dissociative symptoms.
Childhood maltreatment
The Childhood Trauma Questionnaire (CTQ) will be used to measure childhood maltreatment. The scale ranges between 5 and 100 points and higher scores indicate higher childhood maltreatment. CTQ scores will be tested as moderator variable of TMS effects.
Sleep quality: visual analog scales
Sleep quality (delay in sleep onset, calmness, depth of sleep, nightmares, nightly awakenings) will be measured with visual analog scales from 0 to 100. Higher scores represent poor sleep quality.
Delayed discounting task
To test changes in PFC-associated control of impulsive preferences, subjects will perform a delayed discounting paradigm. Participants will be asked to choose between small immediate rewards and larger later rewards. This task will be conducted twice (before and after the iTBS sessions).
Food craving task
Food craving will be measured twice (before and after the iTBS sessions). Participants will be confronted with pictures of candy and dessert in two types of trials. In "NOW" trials, participants will be instructed to consider the immediate consequence of consuming the pictured food, while "LATER" trials will direct participants to think about the long-term consequences.

Full Information

First Posted
February 28, 2020
Last Updated
March 25, 2020
Sponsor
University Hospital, Bonn
search

1. Study Identification

Unique Protocol Identification Number
NCT04325087
Brief Title
Reduction of Trauma-induced Intrusions and Amygdala Hyperreactivity Via Non-invasive Brain Stimulation
Acronym
COOL
Official Title
Reduction of Trauma-induced Intrusions and Amygdala Hyperreactivity Via Non-invasive Brain Stimulation
Study Type
Interventional

2. Study Status

Record Verification Date
March 2020
Overall Recruitment Status
Unknown status
Study Start Date
July 1, 2019 (Actual)
Primary Completion Date
May 30, 2020 (Anticipated)
Study Completion Date
May 30, 2020 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University Hospital, Bonn

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The study will focus on the modulation of intrusive memories via functional magnetic resonance imaging (fMRI)-guided repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex (dlPFC) directly after exposure to a traumatic video.
Detailed Description
Traumatic experiences can lead to posttraumatic stress disorder (PTSD) with clinical manifestations including intrusions, avoidance behavior, and hyperarousal. Unlike most other psychological disorders, a PTSD diagnosis requires a clearly identifiable inciting event. As such, preventive interventions in recently traumatized individuals seem promising. In this randomized, placebo-controlled study the investigators explore the potential of individualized transcranial magnetic stimulation (TMS) to reduce trauma-induced intrusive thoughts by altering functional connectivity between the dorsolateral prefrontal cortex (dlPFC) and amygdala. Subjects will undergo a functional magnetic resonance imaging (fMRI) session consisting of a resting state scan, an emotion recognition task and an anatomical scan at the beginning of the study (day 1). Resting state data will be used to determine individualized TMS targets for every subject, depending on functional connectivity between the dlPFC and amygdala. Subsequently, the analogue trauma model will be used to induce intrusions in healthy subjects. Subjects will be confronted with a video clip from the movie "Irreversible" and they will complete online questionnaires in the following three days to measure intrusive thoughts, trauma disclosure (i.e. duration of conversations about the aversive movie) and sleeping quality. Intermittent theta-burst stimulation (iTBS) will be administered directly after the video clip and on the following two days (day 2-4). Cognitive tasks will be applied before and after iTBS sessions to examine short-term effects of iTBS on a behavioral level. Finally, subjects will undergo a second fMRI session similar to the first one, to probe iTBS-induced changes in functional connectivity and emotional processing (day 5).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Intrusive Thoughts, Post Traumatic Stress Disorder
Keywords
Amygdala, fMRI, Intrusive Thoughts, Post Traumatic Stress Disorder, TMS

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Participants receive either three sessions of iTBS over the dorsolateral prefrontal cortex or three sessions of a placebo stimulation.
Masking
Participant
Allocation
Randomized
Enrollment
120 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Active iTBS
Arm Type
Experimental
Arm Description
Active stimulation of the dlPFC directly after trauma exposure and on the following two days
Arm Title
Placebo iTBS
Arm Type
Placebo Comparator
Arm Description
Same procedure as in the active stimulation group but with a placebo stimulation imitating the sensation of a real iTBS protocol.
Intervention Type
Device
Intervention Name(s)
iTBS
Intervention Description
Administration of an iTBS protocol over the dlPFC
Intervention Type
Device
Intervention Name(s)
Placebo iTBS
Intervention Description
Administration of a placebo TMS protocol over the dlPFC
Primary Outcome Measure Information:
Title
Number and quality of intrusive thoughts
Description
Sum and stress ratings of intrusive thoughts measured on three consecutive days after trauma exposure by an online questionnaire.
Time Frame
Three days after trauma exposure
Title
Changes in resting state functional connectivity
Description
Functional connectivity data will be assessed by two 10-minutes resting state fMRI scans before and after three sessions of TMS treatment over the course of three days. The resting state fMRI analysis will focus on changes in functional connectivity between regions-of-interest (ROIs) associated with intrusive memories (prefrontal cortex, amygdala, precuneus, insula, hippocampus, cingulate cortex). Changes in functional connectivity between the first and second fMRI sessions will be computed on the first level and independent t-tests will be used to compare the verum and sham TMS groups.
Time Frame
10-minutes resting state fMRI scans before and after three sessions of TMS treatment
Title
Changes in neural response to an emotion recognition task
Description
Changes between the first and second fMRI session in the blood-oxygen-level-dependent (BOLD) signal in response to happy, fearful and neutral faces as well as houses will be compared between the experimental groups. Analysis will focus on anatomically defined regions-of-interest (ROI) associated with emotion processing (i.e. amygdala, prefrontal cortex, insula, striatal areas). Changes in the neural response and functional connectivity between the first and second fMRI sessions will be computed on the first level and independent t-tests will be used to compare the verum and sham TMS groups. For analyses of fMRI data, standard procedures of the software SPM12 will be used.
Time Frame
15-minutes emotional face matching fMRI task before and after three sessions of TMS treatment
Secondary Outcome Measure Information:
Title
Changes in executive functioning (One Touch Stockings of Cambridge) and attention (Rapid Visual Information Processing) during iTBS treatment
Description
Cognitive tasks conducted with the CanTab software will be used to measure executive functioning (One Touch Stockings of Cambridge) and attention (Rapid Visual Information Processing) on four different time points during the treatment (pre/post first iTBS, pre/post last iTBS). Changes in executive functioning and attention will be tested as moderator variables of other TMS effects.
Time Frame
15-minutes cognitive tasks pre/post first iTBS and pre/post last iTBS treatment
Title
Trauma disclosure
Description
Trauma disclosure will be measured by online questionnaires on days 2-4. Subjects will be asked to report the number and duration (in minutes) of conversations about the video. Furthermore, subjects have to report to who they talked with about the video. Trauma disclosure will be tested as a moderator variable of TMS effects.
Time Frame
Three days after trauma exposure
Title
Changes in electrodermal responses to the trauma video
Description
Electrodermal responses will be recorded by a BioNomadix System (BIOPAC Systems Inc., Santa Barbara, USA) during a 5-minutes baseline before the start of the trauma video and during the trauma video with two electrodes attached to palm of the right hand.
Time Frame
5 minutes before and during the trauma video
Title
Respiratory changes in response to the trauma video
Description
Respiratory rate will be recorded by a BioNomadix System (BIOPAC Systems Inc., Santa Barbara, USA) during a 5-minutes baseline before the start of the trauma video and during the trauma video with belt attached to the subject's chest. Data will be analyzed for changes in breathing frequency and amplitude in response to the trauma video.
Time Frame
5 minutes before and during the trauma video
Title
Heart rate changes in response to the trauma video
Description
Heart rate will be recorded by a BioNomadix System (BIOPAC Systems Inc., Santa Barbara, USA) during a 5-minutes baseline before the start of the trauma video and during the trauma video.
Time Frame
5 minutes before and during the trauma video
Title
Changes in positive and and negative affect in response to the trauma video
Description
Changes in positive and negative affect will be measured by the PANAS (Positive and Negative Affect Schedule) questionnaire 10 minutes before and 10 minutes after trauma exposure. The PANAS questionnaire consists of two subscale: 1. positive affect (minimum rating = 5, maximum rating = 50), 2. negative affect (minimum rating = 5, maximum rating = 50).
Time Frame
10 minutes before and 10 minutes after trauma exposure
Title
Changes in anxiety in response to the trauma video
Description
Changes in anxiety will be measured by the STAI-Trait (State-Trait Anxiety Inventory) questionnaire immediately 10 minutes before and 10 minutes after trauma exposure.(minimum rating = 20, maximum rating = 80, higher values indicate more state anxiety).
Time Frame
10 minutes before and 10 minutes after trauma exposure
Title
Dissociative symptoms after trauma exposure
Description
Dissociative symptoms after the trauma video will be measured by questionnaires (Dissociation-Tension-Scale acute) and tested as a moderator variable of TMS effects. Subjects score between 0 and 9, with higher values indicating more dissociative symptoms.
Time Frame
10 minutes after trauma exposure
Title
Childhood maltreatment
Description
The Childhood Trauma Questionnaire (CTQ) will be used to measure childhood maltreatment. The scale ranges between 5 and 100 points and higher scores indicate higher childhood maltreatment. CTQ scores will be tested as moderator variable of TMS effects.
Time Frame
Before first fMRI scan
Title
Sleep quality: visual analog scales
Description
Sleep quality (delay in sleep onset, calmness, depth of sleep, nightmares, nightly awakenings) will be measured with visual analog scales from 0 to 100. Higher scores represent poor sleep quality.
Time Frame
Three days after trauma exposure
Title
Delayed discounting task
Description
To test changes in PFC-associated control of impulsive preferences, subjects will perform a delayed discounting paradigm. Participants will be asked to choose between small immediate rewards and larger later rewards. This task will be conducted twice (before and after the iTBS sessions).
Time Frame
Before and three days after trauma exposure
Title
Food craving task
Description
Food craving will be measured twice (before and after the iTBS sessions). Participants will be confronted with pictures of candy and dessert in two types of trials. In "NOW" trials, participants will be instructed to consider the immediate consequence of consuming the pictured food, while "LATER" trials will direct participants to think about the long-term consequences.
Time Frame
Before and three days after trauma exposure

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Healthy subjects Exclusion Criteria: current psychiatric illness current psychiatric medication or psychotherapy past PTSD diagnosis MRI contraindication (e.g. metal in body, claustrophobia) pregnancy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Dirk Scheele, PhD
Phone
+49 (0)228 287
Ext
11151
Email
Dirk.Scheele@ukb.uni-bonn.de
First Name & Middle Initial & Last Name or Official Title & Degree
Mitjan Morr, MSc
Phone
+49 (0)228 287
Ext
19578
Email
Mitjan.Morr@ukbonn.de
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rene Hurlemann, MSc, MD, PhD
Organizational Affiliation
University of Oldenburg
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Psychiatry, University of Bonn
City
Bonn
ZIP/Postal Code
53105
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Dirk Scheele, PhD
Phone
+49 (0)228 287
Ext
11151
Email
Dirk.Scheele@ukb.uni-bonn.de
First Name & Middle Initial & Last Name & Degree
Mitjan Morr, MSc
Phone
+49 (0)228 287
Ext
19578
Email
Mitjan.Morr@ukbonn.de

12. IPD Sharing Statement

Plan to Share IPD
No
Links:
URL
http://renehurlemann.squarespace.com/welcome/
Description
Neuromodulation of Emotion (NEMO) research group

Learn more about this trial

Reduction of Trauma-induced Intrusions and Amygdala Hyperreactivity Via Non-invasive Brain Stimulation

We'll reach out to this number within 24 hrs